Relugolix
Brand name: Orgovyx
Rank #152 of 500 drugs by total cost
$107.3M
Total Cost
38,821
Total Claims
$107.3M
Total Cost
894
Prescribers
$2,763
Cost per Claim
3,528
Beneficiaries
39,354
30-Day Fills
$120K
Avg Cost/Provider
43
Avg Claims/Provider
About Relugolix
Relugolix (sold as Orgovyx) was prescribed 38,821 times by 894 Medicare Part D providers in 2023, costing the program $107.3M. At $2,763 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 149 | Mesalamine (Mesalamine) | $109.3M | 176,079 |
| 150 | Axitinib (Inlyta) | $109.1M | 5,937 |
| 151 | Ipratropium/Albuterol Sulfate (Combivent Respimat) | $108.3M | 353,594 |
| 152 | Relugolix (Orgovyx) | $107.3M | 38,821 |
| 153 | Pen Needle, Diabetic (Ultra-Fine Mini Pen Needle) | $105.0M | 1,305,150 |
| 154 | Divalproex Sodium (Divalproex Sodium) | $103.4M | 1,921,840 |
| 155 | Nilotinib Hcl (Tasigna) | $100.9M | 6,308 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology